Evaluation of immunoglobulins, proinflammatory cytokines and lipid concentrations in patients with diabetic nephropathy treated with continual ambulatory peritoneal dialysis (CAPD)
Donica, H.; Kozioł-Montewka, M.; Ksiazek, A.; Starosławska, E.
Annales Universitatis Mariae Curie-Sklodowska. Sectio D Medicina 55: 73-79
2000
ISSN/ISBN: 0066-2240 PMID: 11482110 Document Number: 526104
Document emailed within 1 workday
Related Documents
Kanjanabuch, T.; Puttipittayathorn, N.; Leelahavanichkul, A.; Lieusuwan, S.; Katavetin, P.; Mahatanan, N.; Sriudom, K.; Chirananthavat, T.; Thongbor, N.; Eiam-Ong, S. 2011: Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients Journal of the Medical Association of Thailand 94(Suppl 4): S119-S125Davies, S.J.; Ogg, C.S.; Cameron, J.S.; Poston, S.; Noble, W.C. 1989: Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD) Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(1): 61-64
Shoji, T.; Nishizawa, Y.; Nishitani, H.; Yamakawa, M.; Morii, H. 1992: High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis Clinical Nephrology 38(5): 271-276
Schröder, C.H.; Bakkeren, J.A.; Weemaes, C.M.; Monnens, L.A. 1989: IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD) Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(4): 261-265
Grzegorzewska, A.; Chmurak, A. 1996: Clinical and kinetic evaluation of continuous ambulatory peritoneal dialysis (CAPD) Przeglad Lekarski 53(8): 619-622
Maksic, D.; Vasilijic, S.; Colic, M.; Stankovic-Popovic, V.; Bokonjic, D. 2009: Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 25: 50-55
Hou, S. 1990: Pregnancy in continuous ambulatory peritoneal dialysis (CAPD) patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 10(3): 201-204
Hortling, L.; Sipilä, R. 1984: Multiresistant Serratia marcescens peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD) successfully treated with Azthreonam (S26,776) a new monobactam antibiotic Clinical Nephrology 21(6): 355
Bozkurt, F.; Keller, E.; Schollmeyer, P.; Kappe, R.; Müller, J. 1988: Candida peritonitis in 2 patients on continuous ambulatory peritoneal dialysis (CAPD) Mycoses Suppl 1: 69-74
Baczyński, D.; Marciniak, M.; Olszowska, A.; Waniewski, J.; Weryński, A.; Wańkowicz, Z. 1998: Evaluation of peritoneal solute transport parameters in diabetics treated with continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 5(29): 274-276
Makulska, I.; Zwolińska, D.; Kiliś-Pstrusińska, K.; Magier, K. 2001: Nutritional status of children treated with continuous ambulatory peritoneal dialysis and ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(58): 219-223
Pongchaiyakul, C.; Pongskul, C.; Ruengjui, S.; Sirivongs, D. 2005: Bone mineral density among patients undergoing continuous ambulatory peritoneal dialysis (CAPD) Journal of the Medical Association of Thailand 88(Suppl 5): S40-S45
Chan, M.K.; Lam, S.S.; Chan, P.C.; Cheng, I.K. 1987: Continuous ambulatory peritoneal dialysis (CAPD): experience with the first 100 patients in a Hong Kong centre International Journal of Artificial Organs 10(2): 77-82
Sharples, E.J.; Varagunam, M.; Sinnott, P.J.; McCloskey, D.J.; Raftery, M.J.; Yaqoob, M.M. 2006: The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(1): 64-68
Carobi, C.; Cozzari, M.; Brugnano, R.; Giombini, L.; Buoncristiani, U. 1985: Continuous ambulatory peritoneal dialysis in patients with polycystic nephropathy Minerva Urologica e Nefrologica 37(4): 459-463
Canaud, B.; Mion, C. 1995: Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis Nephrologie 16(1): 129-135
Wu, M.S.; Yu, C.C.; Wu, C.H.; Haung, J.Y.; Leu, M.L.; Huang, C.C. 1999: Pre-dialysis glycemic control is an independent predictor of mortality in type Ii diabetic patients on continuous ambulatory peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(Suppl 2): S179-S183
De Santo, N.G.; Capodisaca, G.; Senatore, R.; Cicchetti, T.; Cirillo, D.; Damiano, M.; Giordano, C. 1979: Stability of peritoneal urea clearance in continuous ambulatory peritoneal dialysis (18 months experience with CAPD) International Journal of Artificial Organs 2(4): 193-196
Tsai, T.J.; Tsai, H.F.; Wu, M.S.; Chuang, C.M.; Chen, W.Y. 1989: Comparison of therapeutic efficacy of continuous ambulatory peritoneal dialysis between diabetic and non-diabetic patients: three years of experience Journal of the Formosan Medical Association 88(10): 1000-1007
Rottembourg, J.; Issad, B.; Allouache, M. 1993: Insulin prescription, glycemic control, and diabetic complications in diabetics treated by continuous ambulatory peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S232-S235